Clinically severe obesity is also known as
a. morbid obesity.
b. metabolic syndrome.
c. leptin-resistant obesity.
d. psychological-resistant syndrome.
e. Prader-Willi syndrome
Question 2
Which of the following is a feature of prescription drug use for treatment of obesity?
a. Most drugs may be safely prescribed even in otherwise healthy obese people.
b. Most experts believe that drugs should not be used because obesity is not a disease.
c. Most currently available drugs are highly effective in both the short and long term.
d. The use of off-label drugs is common to take advantage of their modest weight loss effects.
e. Although initially effective, most eventually raise the risk of cardiovascular disease to unacceptable levels.
A metabolic pathway
Waardenburg syndrome
Severe contact dermatitis.
Clinically Significant Drug-Disease Interactions in Dentistry
Obesity
Horner’s syndrome